RNAi therapeutics

L'Oréal Invests in OliX Pharmaceuticals via BOLD Fund

South Korean biotech OliX Pharmaceuticals has raised $71 million in a funding round co-led by L'Oréal's venture fund BOLD and Weiss Asset Management.